Skip to main content

Peer Review reports

From: Haemorrhage-related adverse events profles of lenvatinib and pembrolizumab alone or in combination: a real-world pharmacovigilance study based on FAERS database

Original Submission
24 Sep 2024 Submitted Original manuscript
4 Nov 2024 Reviewed Reviewer Report
12 Jan 2025 Reviewed Reviewer Report
31 Jan 2025 Author responded Author comments - Guosheng Zou
5 Feb 2025 Author responded Author comments - Guosheng Zou
Resubmission - Version 2
31 Jan 2025 Submitted Manuscript version 2
19 Feb 2025 Author responded Author comments - Guosheng Zou
Resubmission - Version 3
19 Feb 2025 Submitted Manuscript version 3
Publishing
21 Feb 2025 Editorially accepted
25 Feb 2025 Article published 10.1186/s40360-025-00878-3

You can find further information about peer review here.

Back to article page